Elm and Varnish Tree Extract Composition for Low-Toxicity Anticancer Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The pharmaceutical applicability of elm and varnish trees has been limited due to their perceived toxicity and lack of investigation into their physiological activities, with few studies exploring their potential in anticancer compositions.
Innovation Solution
A composition containing the flowery portion of the elm tree or its extract and the leaf portion of the varnish tree or its extract, specifically using Ulmus hollandica species, which demonstrates strong anticancer activity with low toxicity, allowing for use in pharmaceuticals, foods, and beverages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If varnish tree is used for pharmaceutical materials, then it contains urushiol which is toxic and causes dermatitis, but it has been found that combined composition with elm tree shows low toxicity and excellent anticancer activities
Solution Approach 1:
The patent applies this principle by combining varnish tree (which contains toxic urushiol) with elm tree to convert the harmful toxicity into a beneficial low-toxicity anticancer composition. The combination transforms the harmful property into a useful pharmaceutical application for cancer treatment.
Solution Approach 2:
The patent creates a composite pharmaceutical composition by combining extracts from two different plant sources - elm tree and varnish tree. This composite approach allows the beneficial properties of both plants to work together while mitigating the harmful effects of urushiol through the synergistic combination.
2Adaptability or versatility
If elm and varnish trees are used for pharmaceutical materials, then previous studies showed utility for hypercholesterolemia and arteriosclerosis, but pharmaceutical applicability has been extremely limited beyond these conditions
Solution Approach 1:
The patent demonstrates that the combined composition of elm and varnish trees has multiple pharmaceutical applications beyond the previously known hypercholesterolemia and arteriosclerosis treatments. The composition is now shown to have anticancer activities, expanding its versatility to treat different types of cancer including sarcoma, leukemia, and lymphoma.
3Object-affected harmful factors
If elm tree is used for pharmaceutical materials, then it is readily available and nontoxic, but it has been almost put outside the range of studies for pharmaceutical materials
Solution Approach 1:
The patent merges elm tree (which is nontoxic and readily available) with varnish tree to create a combined composition that maintains the low toxicity of elm while adding the pharmaceutical value of varnish tree. This combination has revitalized research interest in elm tree for pharmaceutical applications, particularly in anticancer therapy.
Data Source
AI summary
An anticancer composition containing a flowery portion of elm tree or its extract and a leaf portion of varnish tree or its extract is safe and shows high activity.